Global Clinical Leader, MD
Daiichi Sankyo · Mallinckrodt · InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Global Clinical Leader, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:16 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT02732275 · DS-3201b in Participants With LymphomasDaiichi Sankyo Co., Ltd. · active not recruiting · Lymphoma, Malignant, Non-hodgkin Lymphoma · study director
- Ph2NCT02544152 · Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel SyndromeSucampo Pharma Americas, LLC · terminated · Irritable Bowel Syndrome · study director
- N/ANCT02000830 · Follow up Study of Patients Having Participated in Clinical Trial 64,185-204InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company · completed · Hyperbilirubinemia, Neonatal · study chair
- Ph3NCT00626028 · Comparison of Inhaled Nitric Oxide and Oxygen in Participants Reactivity During Acute Pulmonary Vasodilator TestingMallinckrodt · completed · Idiopathic Pulmonary Arterial Hypertension, Cardiomyopathy · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:16 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.